196 related articles for article (PubMed ID: 2426465)
1. Site-directed mutagenesis of polyomavirus middle-T antigen sequences encoding tyrosine 315 and tyrosine 250.
Markland W; Oostra BA; Harvey R; Markham AF; Colledge WH; Smith AE
J Virol; 1986 Aug; 59(2):384-91. PubMed ID: 2426465
[TBL] [Abstract][Full Text] [Related]
2. Mapping of the amino-terminal half of polyomavirus middle-T antigen indicates that this region is the binding domain for pp60c-src.
Markland W; Smith AE
J Virol; 1987 Feb; 61(2):285-92. PubMed ID: 2433463
[TBL] [Abstract][Full Text] [Related]
3. The carboxy terminus of pp60c-src is a regulatory domain and is involved in complex formation with the middle-T antigen of polyomavirus.
Cheng SH; Piwnica-Worms H; Harvey RW; Roberts TM; Smith AE
Mol Cell Biol; 1988 Apr; 8(4):1736-47. PubMed ID: 2454396
[TBL] [Abstract][Full Text] [Related]
4. In vitro mutagenesis of the putative membrane-binding domain of polyomavirus middle-T antigen.
Markland W; Cheng SH; Oostra BA; Smith AE
J Virol; 1986 Jul; 59(1):82-9. PubMed ID: 2423706
[TBL] [Abstract][Full Text] [Related]
5. Residual transforming activity of PY1178T, a mutant lacking the principal in vitro tyrosine phosphorylation site, is not affected by removal of the secondary tyrosine phosphorylation site at residue 322.
Schaffhausen BS; Liang TJ; Carmichael GG; Benjamin TL
Virology; 1985 Jun; 143(2):671-5. PubMed ID: 2998034
[TBL] [Abstract][Full Text] [Related]
6. The amino-terminal region of pp60c-src has a modulatory role and contains multiple sites of tyrosine phosphorylation.
Espino PC; Harvey R; Schweickhardt RL; White GA; Smith AE; Cheng SH
Oncogene; 1990 Mar; 5(3):283-93. PubMed ID: 1690377
[TBL] [Abstract][Full Text] [Related]
7. Structural and functional modification of pp60c-src associated with polyoma middle tumor antigen from infected or transformed cells.
Cartwright CA; Hutchinson MA; Eckhart W
Mol Cell Biol; 1985 Oct; 5(10):2647-52. PubMed ID: 2426573
[TBL] [Abstract][Full Text] [Related]
8. Significance of the gastrin homology and surrounding sequences in polyomavirus middle T antigen for cell transformation.
Clark KL; Folk WR
J Virol; 1986 Jan; 57(1):237-45. PubMed ID: 3001348
[TBL] [Abstract][Full Text] [Related]
9. Mutations around the NG59 lesion indicate an active association of polyoma virus middle-T antigen with pp60c-src is required for cell transformation.
Cheng SH; Markland W; Markham AF; Smith AE
EMBO J; 1986 Feb; 5(2):325-34. PubMed ID: 3011402
[TBL] [Abstract][Full Text] [Related]
10. Transformation by polyoma virus middle T antigen.
Courtneidge SA
Cancer Surv; 1986; 5(2):173-82. PubMed ID: 2430702
[TBL] [Abstract][Full Text] [Related]
11. pp60c-src variants containing lesions that affect phosphorylation at tyrosines 416 and 527.
Harvey R; Hehir KM; Smith AE; Cheng SH
Mol Cell Biol; 1989 Sep; 9(9):3647-56. PubMed ID: 2476663
[TBL] [Abstract][Full Text] [Related]
12. Induction of tumor formation and cell transformation by polyoma middle T antigen in the absence of Src.
Thomas JE; Aguzzi A; Soriano P; Wagner EF; Brugge JS
Oncogene; 1993 Sep; 8(9):2521-9. PubMed ID: 7689725
[TBL] [Abstract][Full Text] [Related]
13. 12-O-tetradecanoylphorbol-13-acetate stimulates phosphorylation of the 58,000-Mr form of polyomavirus middle T antigen in vivo: implications for a possible role of protein kinase C in middle T function.
Matthews JT; Benjamin TL
J Virol; 1986 May; 58(2):239-46. PubMed ID: 2422391
[TBL] [Abstract][Full Text] [Related]
14. Structural elements that regulate pp59c-fyn catalytic activity, transforming potential, and ability to associate with polyomavirus middle-T antigen.
Cheng SH; Espino PC; Marshall J; Harvey R; Merrill J; Smith AE
J Virol; 1991 Jan; 65(1):170-9. PubMed ID: 1985196
[TBL] [Abstract][Full Text] [Related]
15. Polyomavirus middle T protein encoded by a retrovirus transforms nonestablished chicken embryo cells.
Kaplan PL; Simon S; Eckhart W
J Virol; 1985 Dec; 56(3):1023-6. PubMed ID: 2999420
[TBL] [Abstract][Full Text] [Related]
16. Association of p62c-yes with polyomavirus middle T-antigen mutants correlates with transforming ability.
Kornbluth S; Cheng SH; Markland W; Fukui Y; Hanafusa H
J Virol; 1990 Apr; 64(4):1584-9. PubMed ID: 1690822
[TBL] [Abstract][Full Text] [Related]
17. Middle tumor antigen of polyomavirus transformation-defective mutant NG59 is associated with pp60c-src.
Bolen JB; Israel MA
J Virol; 1985 Jan; 53(1):114-9. PubMed ID: 2981329
[TBL] [Abstract][Full Text] [Related]
18. Transformation by polyoma virus is drastically reduced by substitution of phenylalanine for tyrosine at residue 315 of middle-sized tumor antigen.
Carmichael G; Schaffhausen BS; Mandel G; Liang TJ; Benjamin TL
Proc Natl Acad Sci U S A; 1984 Feb; 81(3):679-83. PubMed ID: 6322163
[TBL] [Abstract][Full Text] [Related]
19. Analysis of polyomavirus middle-T-antigen-transformed rat cell variants expressing different levels of pp60c-src.
Bolen JB; Amini S; DeSeau V; Reddy S; Shalloway D
J Virol; 1987 Apr; 61(4):1079-85. PubMed ID: 2434664
[TBL] [Abstract][Full Text] [Related]
20. The major site of tyrosine phosphorylation in polyomavirus middle T antigen is not required for transformation.
Mes-Masson AM; Schaffhausen B; Hassell JA
J Virol; 1984 Nov; 52(2):457-64. PubMed ID: 6092671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
